Motor Cortex Function in APOE4 Carriers and Noncarriers

J Clin Neurophysiol. 2021 Nov 1;38(6):553-557. doi: 10.1097/WNP.0000000000000738.

Abstract

Purpose: The ε4 allele of the apolipoprotein-E gene has been associated with disease activity including Alzheimer disease, multiple sclerosis, and cardiovascular disease. Individuals who possess the ε4 variant of this gene (ε4 carriers) also demonstrate higher levels of cognitive impairment and lower motor scores compared with noncarriers. The purpose of this study was to establish whether there is a difference in motor cortex function between apoε4 carriers and noncarriers. We hypothesized that carriers would have lower levels of excitability and excitatory transmitter (glutamate) and similar levels of intracortical inhibition and inhibitory neurotransmitter (gamma-aminobutyric acid) than noncarriers.

Methods: Fifty-two participants provided saliva samples to determine apoε4 carrier status. Measures of motor cortex excitability and inhibition were obtained using transcranial magnetic stimulation, and measures of glutamate and gamma-aminobutyric acid concentrations were obtained using proton magnetic resonance spectroscopy.

Results: No significant differences in transcranial magnetic stimulation (P ≥ 0.19) or proton magnetic resonance spectroscopy measures (P ≥ 0.90) were found between carriers and noncarriers.

Conclusions: The results from this study suggest that motor cortex function, as assessed by transcranial magnetic stimulation measures of excitability and inhibition, and MRS measures of excitatory and inhibitory neurotransmitter are similar in those who possess an apoε4 allele and those who do not.

MeSH terms

  • Alzheimer Disease*
  • Apolipoprotein E4 / genetics
  • Humans
  • Motor Cortex*
  • Transcranial Magnetic Stimulation
  • gamma-Aminobutyric Acid

Substances

  • Apolipoprotein E4
  • gamma-Aminobutyric Acid